Nintedanib: beneficial agent in post-COVID-19 Pulmonary Fibrosis
, , , , , et | 19 juin 2024
Publié en ligne: 19 juin 2024
Pages: 90 - 96
© 2023 Victoria Țau et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.